Newsfeed : Egypt Will Get Sovaldi for $300 Per Treatment

POZ - Health, Life and HIV
Subscribe to:
POZ magazine
E-newsletters
Join POZ: Facebook MySpace Twitter Pinterest
Tumblr Google+ Flickr MySpace
POZ Personals
Sign In / Join
Username:
Password:

Back to home » Newsfeed » July 2014

Most Popular Lessons

The HIV Life Cycle

Shingles

Herpes Simplex Virus

Syphilis & Neurosyphilis

Treatments for Opportunistic Infections (OIs)

What is AIDS & HIV?

Hepatitis & HIV

15 Years Ago In POZ


More News

Click here for more news

Have news about HIV? Send press releases, news tips and other announcements to news@poz.com.


emailprint

July 18, 2014

Egypt Will Get Sovaldi for $300 Per Treatment

Starting in September, Egypt will be allowed to sell Sovaldi (sofosbuvir), Gilead Sciences’ newest drug to treat the hepatitis C virus (HCV), for just one percent of its market price, thanks to a new deal reached between the pharmaceutical company and the nation’s government, Ahram.org reports.

The agreement will provide the drug to Egyptians living with the virus for just LE2,200, or about $300, for a 12-week course of treatment. That’s much lower than Gilead’s initial offer to Egypt back in March, which was around $900 per treatment course.

The country currently has the highest prevalence of hepatitis C in the world; most of it linked to poorly sterilized needles dating back to the 1970s in widespread campaigns to eradicate the parasitic disease schistosomiasis. More than 12 million people in the country live with the virus.

Also in Egypt, the launch of a highly dubious device that the nation’s military government claims can cure both hep C and HIV has been postponed for another six months.

To read the full Ahram.org article, click here.

Search: Egypt, hepatitis C, HCV, Sovaldi, pricing, deal


Scroll down to comment on this story.



Name:

(will display; 2-50 characters)

Email:

(will NOT display)

City:

(will display; optional)

Comment (500 characters left):

(Note: The POZ team reviews all comments before they are posted. Please do not include either ":" or "@" in your comment. The opinions expressed by people providing comments are theirs alone. They do not necessarily reflect the opinions of Smart + Strong, which is not responsible for the accuracy of any of the information supplied by people providing comments.)

Comments require captcha.
Please enter this number for verification:

| Posting Rules



Show comments (0 total)

 
[Go to top]

Join POZ Facebook Twitter Google+ MySpace YouTube Tumblr Flickr
Quick Links
Current Issue

HIV Testing
Safer Sex
Find a Date
Newly Diagnosed
HIV 101
Disclosing Your Status
Starting Treatment
Help Paying for Meds
Search for the Cure
POZ Stories
POZ Opinion
POZ Exclusives
Read the Blogs
Visit the Forums
Job Listings
Events Calendar


    dave41
    Bethany
    Oklahoma


    TanyaB
    Delray Beach
    Florida


    Heartland4now
    Tacoma
    Washington


    pozsmith1
    East Bay
    California
Click here to join POZ Personals!
Ask POZ Pharmacist

Talk to Us
Poll
Survey
Pop Watch

more surveys
Contact Us
We welcome your comments!
[ about Smart + Strong | about POZ | POZ advisory board | partner links | advertising policy | advertise/contact us | site map]
© 2014 Smart + Strong. All Rights Reserved. Terms of use and Your privacy.
Smart + Strong® is a registered trademark of CDM Publishing, LLC.